In SCLC CSCs, ATO significantly inhibited GLI1 expression, resulting in reduced clonogenicity and spheroid formation, as well as tumorigenicity SCLC xenograft models [540]. The gene discussed is GLI1; the disease is small cell lung carcinoma.